Crohn's Disease Clinical Trials

Showing 81-100 of 835 trials

Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

NCT04306939

This is a prospective, descriptive, observational research study designed to observe and document the clinical practice by domain experts, and how the knowledge of new findings that are published in the medical literature affect clinical decision making. The study will evaluate risk factors and co-variants, including genetic variants that are associated with disease progression such as pain, inflammation, organ dysfunction, disability and quality of life.

Chronic PancreatitisInflammatory Bowel DiseasesHepatitis+24 more

University of Pittsburgh120,000 participantsStarted Nov 2014

Pittsburgh, Pennsylvania, United States

RECRUITING

Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation

NCT06001450

The PLANET Study aims to determine the impact of microplastics on intestinal inflammation and gut microbiome in order to understand the role of this pollutant on the risk of developing inflammatory bowel disease (IBD) as well as other diseases. With this information, the researchers hope to characterize better the role of environmental pollutants on IBD and develop novel strategies towards prevention.

Crohns DiseasePregnancyInflammatory Bowel Disease

Icahn School of Medicine at Mount Sinai46 participantsStarted Aug 2023

New York, New York, United States

Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation

Related Searches

CEDUR - German IBD Registry

Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives

The Effect of Vascular Imaging Devices on Success Rates of Peripheral Vascular Access in Pediatric Patients

Study on the Use of Traditional Chinese Medicine Diagnostic Tools to Assist in Identifying the Clinical Characteristics of Inflammatory Bowel Disease and Research on Metabolic Plastids of Tongue Coating

Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Oral Health-related Quality of Life (OHRQoL) in Patients With Inflammatory Bowel Disease (IBD)

Food Limitations In Crohn's Disease and Ulcerative coliTis

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease

Study of Dietary Composition in Crohn's Disease

A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

Treatment of Moderate to Severe Refractory Crohn's Disease

Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study

VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation

The Nordic IBD Treatment Strategy Trial

The Association Between TNFSF4 Polymorphism and CD

AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease